Lifecare Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Joacim Holter

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	3.7yrs
CEO ownership	0.2%
Management average tenure	no data
Board average tenure	3.5yrs

Recent management updates

Recent updates

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Apr 30

CEO

Joacim Holter

3.7yrs

Tenure

Mr. Joacim Holter serves as Head of Investor Relation at Lifecare AS. He has been the Chief Executive Officer at Lifecare AS since September 06, 2020 and had been a Director since 2011. He was the Chairman...

Board Members

Name	Position	Tenure	Compensation	Ownership
Bo Petersson	Independent Director	3.5yrs	no data	no data
Hans Hekland	Independent Director	3yrs	no data	0.15% NOK 646.0k
Lutz Heinemann	Member of Scientific Advisory Board & Independent Director	3.5yrs	no data	no data
David Klonoff	Chairman of Scientific Advisory Board	no data	no data	no data
Morten Krohnstad	Independent Chairman of the Board	3.5yrs	no data	no data
Kåre Birkeland	Member of Scientific Advisory Board	no data	no data	no data
Michael Huth	Member of Scientific Advisory Board	4.3yrs	no data	no data
Trine Teigland	Independent Director	3.9yrs	no data	no data
Tony James	Member of Scientific Advisory Board	less than a year	no data	no data

3.5yrs

Average Tenure

Experienced Board: LIFE's board of directors are considered experienced (3.5 years average tenure).

Lifecare Management

Management criteria checks 1/4

Key information

Recent management updates

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

No independent directors

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Recent updates

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 90 million.

Full year 2023 earnings released: kr0.29 loss per share (vs kr0.17 loss in FY 2022)

Full year 2023 earnings released: kr0.27 loss per share (vs kr0.15 loss in FY 2022)

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

New minor risk - Shareholder dilution

Lifecare AS Announces the Norwegian Food Safety Authority Receives Approval to Start LFC-SEN-002

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 42.5 million.

New major risk - Financial position

Lifecare AS to Report Q1, 2023 Results on May 10, 2023

No independent directors

Lifecare AS Announces Interim Data Analysis of the First In-Human Study

Lifecare as Initiates Clinical Studies of the Smallest Glucose Sensor in the Worldr People Diagnosed with Diabeabetes

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Lifecare AS (OB:LIFE) signed a term sheet agreement to acquire PFÜTZNER Science & Health Institute GmbH for €1.18 million.

Lifecare AS (OB:LIFE) acquired Cantimed Ug (Haftungsbeschrsnkt) from NanoScale Systems Gmbh for €0.65 million.

Chairman of the Board Christian Hysing-Dahl has left the company

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Lifecare AS to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day high: kr6.40

New 90-day low: kr3.62

Lifecare AS Announces Board Appointments

New 90-day low: kr4.00

Lifecare Receives EUR 3.9 Million from the EU Commission for Development of Bionic Invisible Pancreas to Forgetdiabetes

New 90-day high: kr7.00

Chief Scientific Officer recently sold kr270k worth of stock

Lifecare Appoints Joacim Holter as CEO

CEO

Tenure

Board Members

Average Tenure